Skip to main content
. 2022 Jun 18;23(12):6798. doi: 10.3390/ijms23126798

Figure 2.

Figure 2

SBP-101 treatment reduces cancer cell viability in vitro. Lung, pancreatic, and ovarian adenocarcinoma lines were treated with SBP-101 concentrations ranging from 1 to 10μΜ. Cells were collected, and the number of viable cells (determined by trypan blue exclusion) was counted following treatment. SBP-101 treatment reduced the cellular viability in all treated lung (A), pancreatic (B), and ovarian (C) cancer cell lines. IC50 values are listed in Table 1.